Promis Neurosciences Inc (PMN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2016 | |
| Assets | |
| Current Assets | |
| Cash & Cash Equivalents | 538 |
| Marketable Securities | 31 |
| Receivables | 35 |
| Other current assets | 74 |
| TOTAL | $678 |
| Non-Current Assets | |
| PPE Net | 75 |
| Other Non-Current Assets | 52 |
| TOTAL | $126 |
| Total Assets | $731 |
| Liabilities | |
| Current Liabilities | |
| Accounts payable and accrued liabilities | 587 |
| TOTAL | $678 |
| Non-Current Liabilities | |
| TOTAL | $N/A |
| Total Liabilities | $678 |
| Shareholders' Equity | |
| Common Shares | 24,704 |
| Retained earnings | -31,720 |
| Other shareholders' equity | 1,118 |
| TOTAL | $52 |
| Total Liabilities And Equity | $730 |